By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Business of identifying, developing and commercializing pharmaceutical products that target unmet1.03M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States1.03M100.00%